Home Biosimilar Antibodies Immunology & Inflammation IFN null Emapalumab (anti-IFNγ) For research use only.
Not for use in humans.

Emapalumab (anti-IFNγ)

Synonyms: Gamifant

Emapalumab (anti-IFNγ), a monoclonal antibody directed against IFNγ, is the first global approval for the treatment of pediatric and adult patients with primary hemophagocytic lymphohistiocytosis (HLH) with refractory.

Emapalumab (anti-IFNγ)

Selleck's Emapalumab (anti-IFNγ) has been cited by 1 publication

Purity & Quality Control

Choose Selective IFN Inhibitors

Expand to Check More
1. "+" indicates inhibitory effect. Increased inhibition is marked by a higher "+" designation. 2. "✔" indicates inhibitory effect, but without specific value.

Biological Activity

Description Emapalumab (anti-IFNγ), a monoclonal antibody directed against IFNγ, is the first global approval for the treatment of pediatric and adult patients with primary hemophagocytic lymphohistiocytosis (HLH) with refractory.

Product Details

CAS No. 1709815-23-5
Molecular Weight 135 KD
Isotype Human IgG1
Application Emapalumab (anti-IFNγ)
Sterility 0.2 μM filtered
Formulation PBS Buffer, PH 7.4
Storage
(From the date of receipt)		 Store the undiluted solution at 4°C in the dark to avoid freeze-thaw cycles.

Comparison of Clones for

*Literature analysis of various clone (for this target) products available on the market shows that Selleck's selected clones are more frequently applied. (data until September 2024)

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Emapalumab (anti-IFNγ) | Emapalumab (anti-IFNγ) supplier | purchase Emapalumab (anti-IFNγ) | Emapalumab (anti-IFNγ) cost | Emapalumab (anti-IFNγ) manufacturer | order Emapalumab (anti-IFNγ) | Emapalumab (anti-IFNγ) distributor